R&D Meets The Crowdscape: BioMed X Looks Outside For Insight
An extended inter-disciplinary approach to preclinical research may offer the best leads against today’s biggest challenges in medicine.
It is a cliché to say that pharma science loves to collaborate – the hard thing is that leaky decision framework by which good ideas do not get executed.
